Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $29,425 | 14 | 75.2% |
| Consulting Fee | $3,800 | 2 | 9.7% |
| Unspecified | $2,314 | 2 | 5.9% |
| Travel and Lodging | $2,038 | 10 | 5.2% |
| Food and Beverage | $1,565 | 21 | 4.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vericel Corporation | $38,711 | 44 | $0 (2022) |
| DJO, LLC | $138.28 | 1 | $0 (2017) |
| Medical Device Business Services, Inc. | $106.79 | 1 | $0 (2017) |
| Trice Medical, Inc. | $99.03 | 1 | $0 (2018) |
| Flexion Therapeutics, Inc. | $71.47 | 1 | $0 (2018) |
| Smith+Nephew, Inc. | $15.05 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,000 | 1 | Vericel Corporation ($2,000) |
| 2021 | $1,323 | 2 | Vericel Corporation ($1,323) |
| 2020 | $3,111 | 3 | Vericel Corporation ($3,111) |
| 2019 | $10,196 | 12 | Vericel Corporation ($10,181) |
| 2018 | $10,102 | 9 | Vericel Corporation ($9,931) |
| 2017 | $12,410 | 22 | Vericel Corporation ($12,165) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/07/2022 | Vericel Corporation | MACI (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Orthopedics | ||||||
| 03/18/2021 | Vericel Corporation | MACI (Biological) | Honoraria | Cash or cash equivalent | $1,200.00 | General |
| Category: Cellular Therapy | ||||||
| 02/24/2021 | Vericel Corporation | MACI (Biological) | Food and Beverage | In-kind items and services | $122.90 | General |
| Category: Cellular Therapy | ||||||
| 05/05/2020 | Vericel Corporation | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 02/13/2020 | Vericel Corporation | MACI (Biological) | Honoraria | Cash or cash equivalent | $1,200.00 | General |
| Category: Cellular Therapy | ||||||
| 01/29/2020 | Vericel Corporation | MACI (Biological) | Food and Beverage | In-kind items and services | $111.46 | General |
| Category: Cellular Therapy | ||||||
| 10/29/2019 | Vericel Corporation | MACI (Biological) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: Cellular Therapy | ||||||
| 10/29/2019 | Vericel Corporation | MACI (Biological) | Travel and Lodging | In-kind items and services | $197.20 | General |
| Category: Cellular Therapy | ||||||
| 10/29/2019 | Vericel Corporation | MACI (Biological) | Travel and Lodging | In-kind items and services | $14.50 | General |
| Category: Cellular Therapy | ||||||
| 08/22/2019 | Vericel Corporation | MACI (Biological) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: Cellular Therapy | ||||||
| 08/08/2019 | Vericel Corporation | MACI (Biological) | Travel and Lodging | In-kind items and services | $566.55 | General |
| Category: Cellular Therapy | ||||||
| 08/08/2019 | Vericel Corporation | MACI (Biological) | Travel and Lodging | In-kind items and services | $15.00 | General |
| Category: Cellular Therapy | ||||||
| 05/10/2019 | Smith+Nephew, Inc. | META TAN (Device) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Trauma Plates, Screws, and Nails | ||||||
| 04/23/2019 | Vericel Corporation | MACI (Biological) | Honoraria | Cash or cash equivalent | $1,100.00 | General |
| Category: Cellular Therapy | ||||||
| 04/03/2019 | Vericel Corporation | MACI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cellular Therapy | ||||||
| 03/14/2019 | Vericel Corporation | MACI (Biological) | Honoraria | Cash or cash equivalent | $2,200.00 | General |
| Category: Cellular Therapy | ||||||
| 03/14/2019 | Vericel Corporation | MACI (Biological) | Food and Beverage | In-kind items and services | $137.39 | General |
| Category: Cellular Therapy | ||||||
| 01/22/2019 | Vericel Corporation | MACI (Biological) | Honoraria | Cash or cash equivalent | $825.00 | General |
| Category: Cellular Therapy | ||||||
| 11/15/2018 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $71.47 | General |
| Category: Musculoskeletal | ||||||
| 10/18/2018 | Vericel Corporation | MACI _ PEAK Study (Drug) | Honoraria | Cash or cash equivalent | $825.00 | General |
| Category: Approved Product being studied for pediatric use | ||||||
| 08/20/2018 | Vericel Corporation | MACI _ PEAK Study (Drug) | Honoraria | Cash or cash equivalent | $3,300.00 | General |
| Category: Approved Product being studied for pediatric use | ||||||
| 08/10/2018 | Vericel Corporation | MACI _ PEAK Study (Drug) | Honoraria | Cash or cash equivalent | $3,300.00 | General |
| Category: Approved Product being studied for pediatric use | ||||||
| 06/13/2018 | Vericel Corporation | MACI _ PEAK Study (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Approved Product being studied for pediatric use | ||||||
| 05/30/2018 | Trice Medical, Inc. | mi-eye (Device) | Food and Beverage | Cash or cash equivalent | $99.03 | General |
| Category: in-office visualization | ||||||
| 03/28/2018 | Vericel Corporation | MACI _ PEAK Study (Drug) | — | Cash or cash equivalent | $2,200.00 | Research |
| Study: A Study of MACI in Patients Aged 10 to <17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee (PEAK) • Category: Approved Product being studied for pediatric use | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Study of MACI in Patients Aged 10 to <17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee (PEAK) | Vericel Corporation | $2,314 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 149 | 184 | $73,373 | $15,907 |
| 2022 | 4 | 150 | 194 | $73,361 | $17,597 |
| 2021 | 3 | 179 | 246 | $57,733 | $19,392 |
| 2020 | 4 | 177 | 234 | $84,230 | $18,473 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 64 | $16,320 | $4,749 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 81 | $13,932 | $4,731 | 34.0% |
| 23430 | Anchoring of biceps tendon | Office | 2023 | 13 | 13 | $32,981 | $3,656 | 11.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $10,140 | $2,771 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 69 | $17,595 | $5,634 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 86 | $14,792 | $5,094 | 34.4% |
| 23430 | Anchoring of biceps tendon | Office | 2022 | 12 | 12 | $30,444 | $3,695 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $10,530 | $3,174 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 107 | $27,285 | $9,615 | 35.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 109 | $18,748 | $6,633 | 35.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $11,700 | $3,144 | 26.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 72 | 123 | $21,156 | $5,920 | 28.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 62 | $15,810 | $4,696 | 29.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 35 | 35 | $13,650 | $4,109 | 30.1% |
| 29823 | Extensive removal of shoulder joint tissue using an endoscope | Office | 2020 | 14 | 14 | $33,614 | $3,748 | 11.2% |
About Dr. Alison Toth, MD
Dr. Alison Toth, MD is a Orthopaedic Surgery healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982644720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alison Toth, MD has received a total of $39,142 in payments from pharmaceutical and medical device companies, with $2,000 received in 2022. These payments were reported across 49 transactions from 6 companies. The most common payment nature is "Honoraria" ($29,425).
As a Medicare-enrolled provider, Toth has provided services to 655 Medicare beneficiaries, totaling 858 services with total Medicare billing of $71,369. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Location Durham, NC
- Active Since 06/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1982644720
Products in Payments
- MACI (Biological) $14,815
- MACI (Drug) $12,165
- MACI _ PEAK Study (Drug) $9,931
- GRYPHON (Device) $106.79
- mi-eye (Device) $99.03
- Zilretta (Drug) $71.47
- META TAN (Device) $15.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Orthopaedic Surgery Doctors in Durham
Dr. William Jiranek, M.d, M.D
Orthopaedic Surgery — Payments: $8.0M
Dr. Thomas Vail, M.d, M.D
Orthopaedic Surgery — Payments: $5.6M
Christopher Brown, Md, MD
Orthopaedic Surgery — Payments: $3.5M
Dr. Mark Easley, M.d, M.D
Orthopaedic Surgery — Payments: $2.6M
Dr. Samuel Adams, M.d, M.D
Orthopaedic Surgery — Payments: $2.3M
Dr. Michael Bolognesi, M.d, M.D
Orthopaedic Surgery — Payments: $1.9M